Skip to content

Clinical Study of Endocardial Myocardial Biopsy

Clinical Study of Endocardial Myocardial Biopsy

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05718128
Enrollment
100
Registered
2023-02-08
Start date
2021-06-01
Completion date
2031-06-01
Last updated
2023-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Tumor, Cardiomyopathies, Endocardiomyocardial Biopsy, Heart Failure, Myocarditis

Brief summary

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Interventions

PROCEDUREEndocardiomyocardial biopsy

Endocardiomyocardial biopsy

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine; * Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause; * Have the ability to understand the test, can cooperate with investigators.

Exclusion criteria

* Unable to understand or unwilling to fill in informed consent forms or follow visitors.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of MACE-410 yearincidences of MACE-4(cardiovascular death, myocardial infarction, stroke and hospitalized unstable angina)

Countries

China

Contacts

Primary ContactXiaoHong PAN
heartpanxh@163.com+8613857116993

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026